Health care stocks were steady pre-bell Monday, with the iShares Biotechnology ETF (IBB) unchanged and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.1%.
Neurocrine Biosciences (NBIX) has entered into a definitive agreement to acquire Soleno Therapeutics (SLNO) for $53 per share in cash, or a total of $2.9 billion, the companies said. Soleno Therapeutics stock was up more than 32% premarket.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments